Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Dow
Moodys
McKesson
McKinsey

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

ACTIVELLA Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Activella patents expire, and when can generic versions of Activella launch?

Activella is a drug marketed by Amneal Pharms Llc and is included in one NDA.

The generic ingredient in ACTIVELLA is estradiol; norethindrone acetate. There are seventy-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the estradiol; norethindrone acetate profile page.

Drug patent expirations by year for ACTIVELLA
Drug Prices for ACTIVELLA

See drug prices for ACTIVELLA

Drug Sales Revenue Trends for ACTIVELLA

See drug sales revenues for ACTIVELLA

Recent Clinical Trials for ACTIVELLA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Gretchen WellsPhase 4
Teva Pharmaceuticals USAPhase 1

See all ACTIVELLA clinical trials

Recent Litigation for ACTIVELLA

Identify potential future generic entrants

District Court Litigation
Case NameDate
Teva Women's Health, Inc. v. Famy Care Ltd.2014-12-05
TEVA WOMEN'S HEALTH, INC. v. MYLAN PHARMACEUTICALS, INC.2010-03-09
TEVA WOMEN'S HEALTH, INC. v. LUPIN, LTD.2010-02-03

See all ACTIVELLA litigation

Pharmacology for ACTIVELLA
Synonyms for ACTIVELLA
(14beta,17alpha)-17-Ethynyl-17-Hydroxyestr-4-En-3-One
(17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one
(17alpha)-17-ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17alpha)-17-hydroxy-19-norpregn-4-en-20-yn-3-one
(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one
(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
067N596
13-methyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one
17-alpha-19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-
17-alpha-Ethinyl-17-beta-hydroxy-delta(sup:4)-estren-3-one
17-alpha-Ethinylestra-4-en-17-beta-ol-3-one
17-alpha-Ethynyl-17-beta-hydroxy-19-norandrost-4-en-3-one
17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one
17-alpha-Ethynyl-17-hydroxy-4-estren-3-one
17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one
17-alpha-Ethynyl-19-nortestosterone
17-alpha-Ethynyl-4-estren-17-ol-3-one
17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-Ethinyl-19-nor-testosterone
17-Ethinyl-19-nortestosterone
17-Ethynyl-17-hydroxyestr-4-en-3-one (ACD/Name 4.0)
17-ethynyl-17beta-hydroxyestr-4-en-3-one
17-Ethynyl-19-Nortestosterone
17-Hydroxy-(17alpha)-19-Norpregn-4-en-20-yn-3-one
17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17alpha-4-pregnen-20-yn-3-one
17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one
17-hydroxy-19-nor-17alpha-pregn-4-en-20yn-3-one
17alpha-Ethinyl-17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinyl-17beta-hydroxy-delta(sup:4)-estren-3-one
17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinylestra-4-en-17beta-ol-3-one
17alpha-Ethynyl-17 beta-hydroxy-19-nor-4-androsten-3-one
17alpha-Ethynyl-17-hydroxy-4-estren-3-one
17alpha-ethynyl-17-hydroxy-Estr-4-en-3-one
17alpha-Ethynyl-17-hydroxyest-4-en-3-one
17alpha-Ethynyl-17beta-hydroxy-19-nor-4-androsten-3-one
17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one
17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one
17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one
17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one
17alpha-Ethynyl-19-nortestosterone
17alpha-Ethynyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-4-estren-17-ol-3-one
17alpha-hydroxy-19-norpregn-4-en-20-yn-3-one
17alpha-pregn-4-en-20-yn-3-one
17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one
17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one
19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one
19-Nor-17-alpha-ethynyltestosterone
19-Nor-17-alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-
19-Nor-17-ethinyl testosterone
19-Nor-17-ethinyltestosterone
19-Nor-17alpa-ethynyltestosterone
19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one
19-Nor-17alpha-ethynyl-4-androsten-17beta-ol-3-one
19-nor-17alpha-Ethynylandrosten-17beta-ol-3-one
19-Nor-17alpha-ethynyltestosterone
19-Nor-17alpha-pregn-4-en-20-yn-3-one, 17-hydroxy-
19-Nor-17alpha-pregn-4-en-20-yn-3-one, 17-hydroxy- (8CI)
19-Nor-ethindrone
19-Nor-ethinyl--4,5-testosterone
19-Norethindrone
19-Norethindrone, >=98%, powder
19-Norethindrone, VETRANAL(TM), analytical standard
19-Norethinyltestosterone
19-Norethisterone
19-Norpregn-4-en-20-yn-3-one, 17-hydroxy-, (17alpha)-
19-Norpregn-4-en-20-yn-3-one,17-hydroxy-, (17a)-
19-Nortestosterone, 17-ethynyl-
4-Estren-17alpha-ethynyl-17beta-ol-3-one
68-22-4
AC-11100
AC1L1M2R
AI3-26422
AKOS005267172
AN-829
Anhydrohydroxynorprogesterone
Anovulatorio
Anovule
ARONIS24281
BBC/437
BCP28306
BDBM50148732
BPBio1_000074
BRD-K92073408-001-03-3
BRD-K92073408-001-16-5
Brevicon
Brevinor
Brevinor 21
Brevinor 28
Brevinor-1 21
Brevinor-1 28
BRN 1915671
BSPBio_000066
C05028
Camila
Camila (TN)
CAS-68-22-4
CCG-220253
CCRIS 484
CHEBI:7627
CHEMBL1162
Ciclovulan
CJ-22223
Conceplan
Conludaf
Conludag
CPD000499579
CS-2664
D00182
DB00717
Demulen
DSSTox_CID_3380
DSSTox_GSID_23380
DSSTox_RID_77005
DTXSID9023380
EC 200-681-6
EINECS 200-681-6
ENT
Errin
Estr-4-en-3-one, 17alpha-ethynyl-17-hydroxy-
Estrinor
Ethinyl-19-nortestosterone
Ethinylnortestosterone
Ethynylmortestosterone
Ethynylnortestosterone
Gencept
Genora
Gestest
GTPL2880
HMS1568D08
HMS2090D21
HMS2095D08
HMS2231E18
HMS3259C16
HMS3712D08
HSDB 3370
HY-B0554
Jenest
Jenest-28
KS-000048I5
LMST02030097
Loestrin
LS-97425
MCULE-9156628994
Menzol
MFCD00067596
Microneth
Micronett
Micronor
Micronor (TN)
Micronovum
Milli
Mini-Pe
Mini-pill
Minovlar
MLS001076679
MLS001163874
Modicon
MolPort-002-507-131
N.E.E
N.E.E.
N0449
NC00576
NCGC00094738-01
NCGC00179669-01
NCGC00179669-02
NCGC00179669-04
NCGC00255187-01
Nelova
NET
Nodiol
Nor-Q.D
Nor-Q.D.
Nor-QD
Nora-BE
Noraethisteronum
Noralutin
Norcept
Norcept-E
Norcolut
Norcolute
Noresthisterone
Norethadrone
Norethin
Norethin 1/35 E
Norethin 1/50 M
Norethindirone
norethindrone
Norethindrone (Norethisterone)
Norethindrone (Norethisterone), Pharmaceutical Secondary Standard; Certified Reference Material
Norethindrone (USP)
Norethindrone [USAN]
Norethindrone [USP]
Norethindrone Norethisterone
Norethindrone, United States Pharmacopeia (USP) Reference Standard
Norethisteron
Norethisterone
Norethisterone (JP17)
norethisterone (norethindrone)
Norethisterone [INN]
Norethisterone [Progestins]
Norethisterone / norethindrone
Norethisterone for system suitability, European Pharmacopoeia (EP) Reference Standard
Norethisterone, British Pharmacopoeia (BP) Reference Standard
Norethisterone, European Pharmacopoeia (EP) Reference Standard
Norethisteronum
Norethisteronum [INN-Latin]
Norethyndron
Norethynodron
Norethynodrone
Noretisterona
Noretisterona [INN-Spanish]
Noretisterone
Noretisterone [DCIT]
Norfor
Norgestin
Noriday
Noriday 28
Norluten
Norlutin
Norluton
Normapause
Norpregneninlone
Norpregneninolone
Norpregneninotone
NSC-9564
Orlest
Ortho 1 35
Ortho 7 7 7
Ortho-novum
Ortho-Novum 1 35
Ortho-Novum 1 50
Ortho-Novum 7 7 7
Ovcon
Ovysmen 0.5 35
Ovysmen 1 35
Prestwick_646
Prestwick0_000253
Prestwick1_000253
Prestwick2_000253
Prestwick3_000253
Primolut N
Primolut-N
Primolut-N (TN)
Proluteasi
RP17635
s4040
SC 4640
SC-16223
SCHEMBL23390
SMR000499579
SPBio_002285
SR-01000765382
SR-01000765382-3
Synphase
Synphasic 28
T18F433X4S
Tox21_111322
Tox21_111322_1
Tox21_302427
Tri-Norinyl
Triella
Trinovum 21
UNII-T18F433X4S
Utovlan
Utovlar
VIKNJXKGJWUCNN-XGXHKTLJSA-N
W-104686
ZINC85205451

US Patents and Regulatory Information for ACTIVELLA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Llc ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907-002 Dec 28, 2006 AB RX Yes No   Start Trial   Start Trial   Start Trial
Amneal Pharms Llc ACTIVELLA estradiol; norethindrone acetate TABLET;ORAL 020907-001 Nov 18, 1998 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Merck
Moodys
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.